{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:15:39Z","timestamp":1788066939144,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008238","name":"Hebei Provincial Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154378","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:57:59Z","timestamp":1785884279000},"page":"154378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CD19 CAR-macrophage suppressed the progression of DLBCL via modulating SYK\/SHP2\/TBK1\/TFEB signaling"],"prefix":"10.1016","volume":"832","author":[{"given":"Xikui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154378_bib1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.omto.2023.08.009","article-title":"Hypoxia-regulated secretion of IL-12 enhances antitumor activity and safety of CD19 CAR-T cells in the treatment of DLBCL","volume":"30","author":"Zhou","year":"2023","journal-title":"Mol. Ther. Oncolytics"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154378_bib2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neo.2020.11.010","article-title":"U-RT1 - a new model for Richter transformation","volume":"23","author":"Schmid","year":"2021","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154378_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1158\/2643-3230.BCD-22-0007","article-title":"Distinct genetically determined origins of Myd88\/BCL2-Driven aggressive lymphoma rationalize targeted therapeutic intervention strategies","volume":"4","author":"Fl\u00fcmann","year":"2023","journal-title":"Blood Cancer Discov."},{"issue":"22","key":"10.1016\/j.bbrc.2026.154378_bib4","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.3390\/cells11223692","article-title":"CAR-macrophages and CAR-T cells synergistically kill tumor cells in vitro","volume":"11","author":"Liu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.154378_bib5","article-title":"Progress and prospect of immunotherapy for triple-negative breast cancer","volume":"12","author":"Luo","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154378_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40169-019-0224-y","article-title":"Cell membrane protein functionalization of nanoparticles as a new tumor-targeting strategy","volume":"8","author":"Pasto","year":"2019","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.154378_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1430760","article-title":"The role of nociceptive neurons in allergic rhinitis","volume":"15","author":"Cong","year":"2024","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.bbrc.2026.154378_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12468","article-title":"Sympathetic nerve infiltration promotes stomach adenocarcinoma progression via norepinephrine\/\u03b22-adrenoceptor\/YKL-40 signaling pathway","volume":"8","author":"Qi","year":"2022","journal-title":"Heliyon"},{"issue":"21","key":"10.1016\/j.bbrc.2026.154378_bib9","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.3390\/cancers14215460","article-title":"The monocyte, a maestro in the tumor microenvironment (TME) of breast cancer","volume":"14","author":"Amer","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"19","key":"10.1016\/j.bbrc.2026.154378_bib10","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.3390\/cells11193043","article-title":"Post-translational modifications of cGAS-STING: a critical switch for immune regulation","volume":"11","author":"Yu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.154378_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12943-015-0474-2","article-title":"Novel drug targets for personalized precision medicine in relapsed\/refractory diffuse large B-cell lymphoma: a comprehensive review","volume":"14","author":"Camicia","year":"2015","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154378_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/cancers16010039","article-title":"Evolving CAR-T-Cell therapy for cancer treatment: from scientific discovery to cures","volume":"16","author":"Majumder","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154378_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/cancers13010134","article-title":"The role of antigen processing and presentation in cancer and the efficacy of immune checkpoint inhibitor immunotherapy","volume":"13","author":"Mpakali","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.154378_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.852147","article-title":"Glycoconjugate nanoparticle-based systems in cancer immunotherapy: novel designs and recent updates","volume":"13","author":"Barchi","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154378_bib15","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1002\/hem3.89","article-title":"Primary central nervous system lymphomas: EHA-ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"8","author":"Ferreri","year":"2024","journal-title":"HemaSphere"},{"issue":"11","key":"10.1016\/j.bbrc.2026.154378_bib16","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41423-024-01220-3","article-title":"Silencing of SIRP\u03b1 enhances the antitumor efficacy of CAR-M in solid tumors","volume":"21","author":"Zhang","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154378_bib17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.immuni.2010.03.014","article-title":"Indirect inhibition of toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins","volume":"32","author":"Wang","year":"2010","journal-title":"Immunity"},{"issue":"43","key":"10.1016\/j.bbrc.2026.154378_bib18","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207280119","article-title":"Endocytosis triggers V-ATPase-SYK-mediated priming of cGAS activation and innate immune response","volume":"119","author":"Yang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.bbrc.2026.154378_bib19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/tra.12396","article-title":"Ligation of Fc\u03b3R alters phagosomal processing of protein via augmentation of NADPH oxidase activity","volume":"17","author":"Balce","year":"2016","journal-title":"Traffic"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154378_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13046-024-02971-7","article-title":"A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity","volume":"43","author":"Zhang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154378_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007955","article-title":"Host cell depletion of tryptophan by IFN\u03b3-induced Indoleamine 2,3-dioxygenase 1 (IDO1) inhibits lysosomal replication of Coxiella burnetii","volume":"15","author":"Ganesan","year":"2019","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154378_bib22","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41556-020-0549-1","article-title":"Mammalian Atg8 proteins and the autophagy factor IRGM control mTOR and TFEB at a regulatory node critical for responses to pathogens","volume":"22","author":"Kumar","year":"2020","journal-title":"Nat. Cell Biol."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154378_bib23","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1080\/15548627.2019.1707494","article-title":"Evidence for lysosomal biogenesis proteome defect and impaired autophagy in preeclampsia","volume":"16","author":"Nakashima","year":"2020","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.bbrc.2026.154378_bib24","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154378_bib25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.molimm.2006.01.013","article-title":"IFN-gamma-induced upregulation of Fcgamma-receptor-I during activation of monocytic cells requires the PKR and NFkappaB pathways","volume":"44","author":"K\u00e5rehed","year":"2007","journal-title":"Mol. Immunol."},{"issue":"24","key":"10.1016\/j.bbrc.2026.154378_bib26","doi-asserted-by":"crossref","first-page":"11964","DOI":"10.1073\/pnas.89.24.11964","article-title":"Interferon gamma rapidly induces in human monocytes a DNA-binding factor that recognizes the gamma response region within the promoter of the gene for the high-affinity Fc gamma receptor","volume":"89","author":"Wilson","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154378_bib27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/ijms17040477","article-title":"Exogenous C2 ceramide suppresses matrix metalloproteinase gene expression by inhibiting ROS production and MAPK signaling pathways in PMA-Stimulated human astroglioma cells","volume":"17","author":"Jung","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154378_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ymthe.2016.10.020","article-title":"Phase 1 results of ZUMA-1: a multicenter study of KTE-C19 Anti-CD19 CAR T cell therapy in refractory aggressive lymphoma","volume":"25","author":"Locke","year":"2017","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154378_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154378_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in adult relapsed or refractory diffuse large B-Cell lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154378_bib31","first-page":"669","article-title":"FDA approves first CAR T therapy","volume":"16","author":"Mullard","year":"2017","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T04:19:36Z","timestamp":1788063576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26011423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S0006291X26011423"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154378","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD19 CAR-macrophage suppressed the progression of DLBCL via modulating SYK\/SHP2\/TBK1\/TFEB signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154378"}}